BWM
VRTX icon

Bulltick Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bulltick Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-9,102
Closed -$3.56M – 145
2025
Q3 		$3.56M Buy
9,102
+7
+0.1% +$2.92K 0.84% 39
2025
Q2 		$4.05M Buy
9,095
+6
+0.1% +$2.77K 1% 33
2025
Q1 		$4.41M Buy
9,089
+17
+0.2% +$7.92K 1.17% 26
2024
Q4 		$3.65M Hold
9,072
– – 0.84% 29
2024
Q3 		$4.22M Sell
9,072
-10,210
-53% -$4.9M 1.02% 30
2024
Q2 		$9.04M Hold
19,282
– – 2.23% 16
2024
Q1 		$8.06M Sell
19,282
-630
-3% -$266K 1.38% 24
2023
Q4 		$8.1M Sell
19,912
-565
-3% -$209K 1.84% 19
2023
Q3 		$7.12M Sell
20,477
-930
-4% -$325K 1.71% 21
2023
Q2 		$7.53M Sell
21,407
-140
-0.6% -$47.2K 1.67% 24
2023
Q1 		$6.79M Sell
21,547
-7,689
-26% -$2.31M 1.76% 22
2022
Q4 		$8.44M Sell
29,236
-5,555
-16% -$1.69M 2.4% 17
2022
Q3 		$10.1M Sell
34,791
-7
-0% -$2.01K 3.02% 8
2022
Q2 		$9.81M Hold
34,798
– – 2.62% 14
2022
Q1 		$9.08M Sell
34,798
-5,374
-13% -$1.28M 2.05% 19
2021
Q4 		$8.82M Sell
40,172
-2,146
-5% -$417K 1.74% 25
2021
Q3 		$7.68M Sell
42,318
-1,575
-4% -$308K 1.74% 28
2021
Q2 		$8.85M Buy
43,893
+41,906
+2,109% +$8.77M 2.04% 24
2021
Q1 		$427K Buy
1,987
+728
+58% +$160K 0.12% 60
2020
Q4 		$298K Buy
+1,259
New +$289K 0.09% 79

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bulltick Wealth Management's VRTX Position: Q4 2025 in Review

Bulltick Wealth Management sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 9,102 shares — an estimated $3.56M sold.

Bulltick Wealth Management first reported a position in VRTX in Q4 2020 and held it in 20 quarters. The position peaked at $10.1M in Q3 2022. 1,670 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Bulltick Wealth Management reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Bulltick Wealth Management sold 9,102 Vertex Pharmaceuticals shares in Q4 2025, an estimated $3.56M.
  • Bulltick Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2020 and held it in 20 quarters.
  • Bulltick Wealth Management's Vertex Pharmaceuticals position peaked at $10.1M in Q3 2022.
  • 1,670 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Bulltick Wealth Management's 13F filing for Q4 2025, filed 17 Feb 2026.